DrugCombination product
Zabadinostat clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 3
Stephen Chan Lam (1) · Oxford University Hospitals NHS Trust (1) · ImmunityBio, Inc. (1) · University College, London (1)
Often tested with
Tested in the same studies.
Nogapendekin alfa inbakicept (1) · Sotevtamab (1) · Albumin-Bound Paclitaxel (1) · Paclitaxel (1) · Gemcitabine (1) · Pembrolizumab (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses zabadinostat is read from its arms, and is right about nine times in ten.
Testing it · 4
- Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic CancerWithdrawnPhase 1ImmunityBio, Inc.NCT07488884Written as Zabadinostat (CXD101)
- CXD101 in Immunotherapy-related Liver CancerActive, not recruitingPhase 2Stephen Chan LamNCT05873244Written as Zabadinostat (CXD101) and Geptanolimab
- Phase 1 Trial of CXD101 in Patients With Advanced CancerCompletedPhase 1Oxford University Hospitals NHS TrustNCT01977638Written as CXD101
- A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell LymphomaWithdrawnPhase 1/2University College, LondonNCT03873025Written as Pembrolizumab and CXD101
Codes
What other systems call zabadinostat · ClinicalTrials.gg INT015123
- UNII (FDA) 5TNV87ICD2ZABADINOSTATConfirmed FDA, Wikidata
- Wikidata Q119852211zabadinostatConfirmed FDA, Wikidata
- NCI Thesaurus C112177ZabadinostatOne source FDA
- DrugBank DB16182One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5TNV87ICD2 | ZABADINOSTAT | Confirmed FDA, Wikidata |
| Wikidata | Q119852211 | zabadinostat | Confirmed FDA, Wikidata |
| NCI Thesaurus | C112177 | Zabadinostat | One source FDA |
| DrugBank | DB16182 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.